Prostate Cancer Life Expectancy

What factors affect prostate cancer life expectancy?

Prostate Cancer Life Expectancy Many patients wonder about prostate cancer life expectancy. If prostate cancer is localized, patients have a 95% chance of living more than five years, explains Dr. Tutrone. Thanks to the development of newer treatments, prostate cancer life expectancy is much longer than in the past.

If the cancer is localized to the prostate, and a patient’s elects either radiation therapy or surgery, there is a greater than 92% chance of living 10 years and not dying from the prostate cancer. The prostate cancer life expectancy of men with metastatic disease that is in the bones or lymph nodes is quite variable, but many can live over 5 or 10 years.


Ronald F. Tutrone, Jr., MD, FACS: The good news about prostate cancer is that if it is localized to your prostate, you have a greater than 95% chance of living over five years.  Thanks to the development of newer treatments, men with metastatic disease can have an excellent long term survival as well.  If your cancer is localized to the prostate and you receive either radiation therapy or surgery, you have a greater than 92% chance of living 10 years and not dying from the prostate cancer.  The life expectancy of men with metastatic disease that is in the bones or lymph nodes is quite variable, but many men can live over 5 or 10 years.  In fact, 50% of men with hormone sensitive metastatic disease will live greater than five years.  Thanks to many advances for advanced prostate cancer, men can have excellent quality of life and longevity with advanced prostate cancer.  In men whose prostate cancer is metastatic and has become hormone refractory, the average life expectancy is about 18 to 20 months with newer treatments available as well as clinical trials even this can be extended beyond two years.  The bottom line is that there are many treatment options and these should be discussed openly with your urologist.

Additional Links:
WebMD — Prostate Cancer: Treatments by Stage
Prostate Cancer — American Cancer Society
Jeldres C, Latouff JB, Saad F. –Predicting life expectancy in prostate cancer patients.

Ronald Trutone, Jr.
Dr. Tutrone is the Medical Director of Chesapeake Urology Research Associates (CURA) and Chief of Urology at the Greater Baltimore Medical Center. He has been voted a “Top Doc” by Baltimore Magazine three times, and has authored numerous articles in the urology literature.
Ronald Trutone, Jr.

Latest posts by Ronald Trutone, Jr. (see all)